These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33470904)

  • 1. Prevalence of Stimulant, Hallucinogen, and Dissociative Substances Detected in Biological Samples of NPS-Intoxicated Patients in Italy.
    Papa P; Valli A; Di Tuccio M; Buscaglia E; Brambilla E; Scaravaggi G; Gallo M; Locatelli CA
    J Psychoactive Drugs; 2021; 53(3):247-255. PubMed ID: 33470904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intoxications in the STRIDA project involving a panorama of psychostimulant pyrovalerone derivatives, MDPV copycats.
    Beck O; Bäckberg M; Signell P; Helander A
    Clin Toxicol (Phila); 2018 Apr; 56(4):256-263. PubMed ID: 28895757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity evaluation of α-pyrrolidinovalerophenone (α-PVP): results from intoxication cases within the STRIDA project.
    Beck O; Franzén L; Bäckberg M; Signell P; Helander A
    Clin Toxicol (Phila); 2016 Aug; 54(7):568-75. PubMed ID: 27412885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review.
    Mohr ALA; Logan BK; Fogarty MF; Krotulski AJ; Papsun DM; Kacinko SL; Huestis MA; Ropero-Miller JD
    J Anal Toxicol; 2022 Jul; 46(6):e116-e185. PubMed ID: 35445267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intoxications by the dissociative new psychoactive substances diphenidine and methoxphenidine.
    Helander A; Beck O; Bäckberg M
    Clin Toxicol (Phila); 2015 Jun; 53(5):446-53. PubMed ID: 25881797
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2013-2016: A Review.
    Logan BK; Mohr ALA; Friscia M; Krotulski AJ; Papsun DM; Kacinko SL; Ropero-Miller JD; Huestis MA
    J Anal Toxicol; 2017 Sep; 41(7):573-610. PubMed ID: 28459969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. I like the old stuff better than the new stuff? Subjective experiences of new psychoactive substances.
    Matthews A; Sutherland R; Peacock A; Van Buskirk J; Whittaker E; Burns L; Bruno R
    Int J Drug Policy; 2017 Feb; 40():44-49. PubMed ID: 27939599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of NPS Based Confirmed Overdose Cases: The STRIDA Project.
    Helander A; Bäckberg M
    Handb Exp Pharmacol; 2018; 252():461-473. PubMed ID: 30135990
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatalities associated with NPS stimulants in the Greater Cologne area.
    Lehmann S; Kieliba T; Thevis M; Rothschild MA; Mercer-Chalmers-Bender K
    Int J Legal Med; 2020 Jan; 134(1):229-241. PubMed ID: 31735981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [New psychoactive substances in emergency medicine].
    Marinowitz R; Strube J; Schaper A
    Nervenarzt; 2024 Jan; 95(1):28-34. PubMed ID: 38189941
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biomedical analysis of New Psychoactive Substances (NPS) of natural origin.
    Lo Faro AF; Di Trana A; La Maida N; Tagliabracci A; Giorgetti R; Busardò FP
    J Pharm Biomed Anal; 2020 Feb; 179():112945. PubMed ID: 31704129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Novel psychoactive substances: the pharmacology of stimulants and hallucinogens.
    Schifano F; Papanti GD; Orsolini L; Corkery JM
    Expert Rev Clin Pharmacol; 2016 Jul; 9(7):943-54. PubMed ID: 26985969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and circumstances of death related to new psychoactive stimulants and hallucinogens in Australia.
    Darke S; Duflou J; Peacock A; Farrell M; Lappin J
    Drug Alcohol Depend; 2019 Nov; 204():107556. PubMed ID: 31546120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug trends and harm related to new psychoactive substances (NPS) in Sweden from 2010 to 2016: Experiences from the STRIDA project.
    Helander A; Bäckberg M; Beck O
    PLoS One; 2020; 15(4):e0232038. PubMed ID: 32324788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 3-MeO-PCP intoxication in two young men: First in vivo detection in Italy.
    Bertol E; Pascali J; Palumbo D; Catalani V; Di Milia MG; Fioravanti A; Mari F; Vaiano F
    Forensic Sci Int; 2017 May; 274():7-12. PubMed ID: 28057371
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intended and unintended use of cathinone mixtures.
    Guirguis A; Corkery JM; Stair JL; Kirton SB; Zloh M; Schifano F
    Hum Psychopharmacol; 2017 May; 32(3):. PubMed ID: 28657191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of synthetic stimulants and hallucinogens in a cohort of electronic dance music festival attendees.
    Mohr ALA; Friscia M; Yeakel JK; Logan BK
    Forensic Sci Int; 2018 Jan; 282():168-178. PubMed ID: 29216523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phencyclidine analog use in Sweden--intoxication cases involving 3-MeO-PCP and 4-MeO-PCP from the STRIDA project.
    Bäckberg M; Beck O; Helander A
    Clin Toxicol (Phila); 2015 Nov; 53(9):856-64. PubMed ID: 26295489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prodrugs of New Psychoactive Substances (NPS): A New Challenge.
    Elliott SP; Holdbrook T; Brandt SD
    J Forensic Sci; 2020 May; 65(3):913-920. PubMed ID: 31943218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. X-Ray powder diffraction - A non-destructive and versatile approach for the identification of new psychoactive substances.
    Jurásek B; Bartůněk V; Huber Š; Kuchař M
    Talanta; 2019 Apr; 195():414-418. PubMed ID: 30625563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.